ON DEMAND WEBINAR
Duration: 1 hour​

Scaling digital health and drug‑plus‑solution programs globally remains a persistent challenge for pharma leaders. Global teams seek efficiency and consistency, while local markets push for adaptation, often without a shared, evidence‑based way to decide when either is justified.

This webinar explores how behavioral science can support more disciplined global‑local decisions, helping teams distinguish between elements that should scale consistently across markets and those that legitimately require local adaptation. Rather than relying on assumptions or market‑by‑market reinvention, the session focuses on aligning global strategy with real‑world execution.

Designed for senior leaders in commercial, digital health, and medical affairs, this session provides a pragmatic framework for scaling digital health programs with greater confidence, consistency, and effectiveness across regions.

Key learning areas include:

• How to identify universal behavioral drivers and frictions that can anchor global digital health programs
• Which elements of digital health and patient support initiatives should remain globally consistent
• How to determine where and why local adaptation is justified, based on healthcare system, regulatory, operational, and cultural realities
• Practical ways to reduce duplication across markets while maintaining local relevance and impact

SPEAKERS

Martin Peters
Head Integrated Insights, CRM
Novartis

Sean Gill
Director of Behaviour Science (Product)
S3 Connected Health

William Lyons
Marketing Director
S3 Connected Health